Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy

Polivka, Laura; Revol, M.; Battistella, Maxime; Bachelez, H.

doi:10.1159/000452325

Cited by 4 publications

(2 citation statements)

References 10 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The absence of any signs of lupus relapse or postsurgical complications in the short and long term is encouraging. In this case, it seems safer to perform it in patients with stable disease [4]. Nevertheless, it is essential that surgeons have a thorough knowledge of vascular anatomy, as some cases of irreversible blindness have been reported [5].…”

Section: Discussionmentioning

confidence: 93%

Lipofilling Technique For Facial Lipoatrophy Secondary to Lupus Profundus: A Case Report

Imane¹

2023

J Clin Med Res.

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 93%

Lipofilling Technique For Facial Lipoatrophy Secondary to Lupus Profundus: A Case Report

Imane¹

2023

J Clin Med Res.

View full text Add to dashboard Cite

show abstract

“…Successful fat transfer has been reported in both lupus panniculitis and DLE (Table 4). 1,40–47 Complications from the procedure are rare but can include fat necrosis requiring drainage, as seen in one case report 45 . Adequate control of the underlying inflammatory disease prior to fat transfer may help facilitate optimal results.…”

Section: Methodsmentioning

confidence: 99%

Treatments for disease damage in cutaneous lupus erythematosus: A narrative review

Joseph

Abbas

Chong

2021

Dermatologic Therapy

View full text Add to dashboard Cite

Cutaneous lupus erythematosus (CLE) is an autoimmune photosensitive disorder that affects the skin. CLE lesions can have signs of skin damage including dyspigmentation, scarring, atrophy and/or alopecia. Disease damage secondary to CLE can be cosmetically disfiguring and causes patients significant distress. While many current treatments for CLE focus primarily on reducing inflammation, there are few options for managing disease damage. Providers currently lack strong guidance on managing CLE damage due to the paucity of literature on this topic. Because of this knowledge gap, we aim to provide an overview of what is currently known about the pathogenesis and management of signs of disease damage in CLE. In this narrative review, Pubmed, Ovid Medline, and Google scholar were searched for relevant articles assessing pathogenesis and treatment of disease damage. Therapeutic options for CLE damage, including hyperpigmentation (laser and camouflage), hypopigmentation (melanocyte grafting and camouflage), scarring (laser, dermabrasion, and camouflage), atrophy (filler, fat transplantation, and flap procedures), and scarring alopecia (hair transplantation and camouflage) were identified. We found that investigations of therapeutics for CLE disease damage primarily consist of case reports and small case series. Reported adverse events due to treatment for CLE disease damage range from temporary erythema and discomfort to disease reactivation and pigmentary defects. There are various treatments for disease damage for each sign of disease damage. However, more robust investigations are needed to assess disease pathogenesis and improve treatments of disease damage due to CLE.

show abstract

Lupus Erythematosus and Antiphospholipid Syndrome

Dutz,

Khosravi‐Hafshejani

2024

Rook's Textbook of Dermatology

View full text Add to dashboard Cite

Lupus erythematosus is an autoimmune disease that commonly affects the skin, and may present with cutaneous only disease. This chapter reviews the forms of cutaneous lupus‐specific skin disease (discoid lupus, subacute cutaneous lupus, lupus tumidus and acute cutaneous lupus), their clinical features, pathogenesis and treatment. A review of systemic lupus erythematosus is also provided with a discussion of diagnosis, clinical features, cutaneous aspects and treatment, germane for the dermatologist. Clinical features of neonatal lupus erythematosus and the antiphospholipid antibody syndrome, more commonly seen in systemic lupus erythematosus kindreds, are also discussed.

show abstract

Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy

Cited by 4 publications

References 10 publications

Lipofilling Technique For Facial Lipoatrophy Secondary to Lupus Profundus: A Case Report

Lipofilling Technique For Facial Lipoatrophy Secondary to Lupus Profundus: A Case Report

Treatments for disease damage in cutaneous lupus erythematosus: A narrative review

Lupus Erythematosus and Antiphospholipid Syndrome

Contact Info

Product

Resources

About